Starting with January 1, the persons with diabetes, high blood pressure and respiratory infections will have access to four more international common names of drugs, IPN reports.
According to the National House of Social Insurance, among the fully or partially compensated drugs are sitagliptinum, perindoprilum+indapamidum, budesonidum or budesonidum+formoterol fumarate dihydrate and fluticasonum.
Also, as of January 1, the patients who need palliative care benefit from three more preparations that are on the list of compensated drugs, namely amitriptilylinum, gabapentinum and diazepamum.
According to the estimates of the National House of Social Insurance, about 24 million lei a year is needed to compensate the new medicines. The money was earmarked in the mandatory health insurance funds. The decision to add the new preparations to the list of compensated drugs was taken by the Council for Compensated Medicines in December 2022.
- The shortage of psychiatrists, signaled by the People’s Advocate Office
- The Venice Commission calls for a review of the conditions for withdrawing deputies’ mandates and protecting the opposition
- Moldova has signed a loan agreement with the EBRD for over 102 million euros, funds for the rehabilitation of irrigation systems
- Airlines will not be able to impose the granting of vouchers instead of compensation for passengers
- The Republic of Moldova and the Council of Europe will identify new cooperation priorities
